Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (vol 24, 16, 2024)
| dc.contributor.author | Tasci, Elif Senocak | |
| dc.contributor.author | Oyan, Basak | |
| dc.contributor.author | Sonmez, Ozlem | |
| dc.contributor.author | Mutlu, Arda Ulas | |
| dc.contributor.author | Atci, Muhammed Mustafa | |
| dc.contributor.author | Sakin, Abdullah | |
| dc.contributor.author | Oner, Irem | |
| dc.contributor.author | Cinkir, Havva Yesil | |
| dc.contributor.author | Eryilmaz, Melek Karakurt | |
| dc.contributor.author | Caglayan, Dilek | |
| dc.contributor.author | Balcik, Onur Yazdan | |
| dc.contributor.author | Paksoy, Nail | |
| dc.contributor.author | Karabulut, Senem | |
| dc.contributor.author | Salim, Derya Kivrak | |
| dc.contributor.author | Bilir, Cemil | |
| dc.contributor.author | Ozen, Mirac | |
| dc.contributor.author | Ozcelik, Melike | |
| dc.contributor.author | Arican, Ali | |
| dc.contributor.author | Akagunduz, Baran | |
| dc.contributor.author | Inal, Ali | |
| dc.contributor.author | Aydin, Dincer | |
| dc.contributor.author | Ozer, Leyla | |
| dc.contributor.author | Gulmez, Ahmet | |
| dc.contributor.author | Turhal, Nazim Serdar | |
| dc.contributor.author | Esen, Selin Akturk | |
| dc.contributor.author | Algin, Efnan | |
| dc.contributor.author | Akbas, Sinem | |
| dc.contributor.author | Iriagac, Yakup | |
| dc.contributor.author | Sakalar, Teoman | |
| dc.contributor.author | Unal, Caglar | |
| dc.contributor.author | Er, Ozlem | |
| dc.contributor.author | Secmeler, Saban | |
| dc.contributor.author | Bozkurt, Mustafa | |
| dc.date.accessioned | 2026-11-05T11:05:38Z | |
| dc.date.issued | 2024 | |
| dc.description.issue | 1 | |
| dc.description.pages | 114 | |
| dc.description.volume | 24 | |
| dc.identifier.doi | 10.1186/s12885-024-11863-0 | |
| dc.identifier.issn | 1471-2407 | |
| dc.identifier.uri | https://doi.org/10.1186/s12885-024-11863-0 | |
| dc.identifier.uri | https://openaccess.acibadem.edu.tr/handle/11443/11325 | |
| dc.identifier.wos | WOS:001148300200002 | |
| dc.language.iso | en | |
| dc.publisher | BMC | |
| dc.relation.hasversion | 10.1186/s12885-024-11863-0 | |
| dc.relation.ispartof | BMC CANCER | |
| dc.subject | Oncology | |
| dc.title | Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (vol 24, 16, 2024) | |
| dc.type | Correction | |
| oaire.citation.edition | Science Citation Index Expanded (SCI-EXPANDED) | |
| oaire.citation.issue | 1 | |
| oaire.citation.volume | 24 | |
| person.identifier.orcid | 0000-0002-7197-211X | |
| person.identifier.orcid | 0000-0002-1372-4791 | |
| person.identifier.orcid | 0000-0001-8421-9234 | |
| person.identifier.orcid | 0000-0002-7433-3591 | |
| person.identifier.rid | A-3920-2015 | |
| person.identifier.rid | KVA-7930-2024 | |
| person.identifier.rid | A-2491-2017 | |
| person.identifier.rid | AAS-7557-2020 | |
| person.identifier.rid | AAT-3594-2020 | |
| person.identifier.rid | X-1330-2018 | |
| person.identifier.rid | ABX-6180-2022 | |
| person.identifier.rid | KBD-3048-2024 | |
| person.identifier.rid | AAJ-4421-2020 | |
| person.identifier.rid | AAO-5495-2020 | |
| person.identifier.rid | GXM-6652-2022 | |
| person.identifier.rid | AAC-7597-2019 | |
| person.identifier.rid | LIG-4758-2024 | |
| person.identifier.rid | ITT-4695-2023 | |
| person.identifier.rid | HKF-3015-2023 | |
| person.identifier.rid | HME-1300-2023 | |
| person.identifier.rid | ABI-8218-2020 | |
| person.identifier.rid | D-1578-2015 | |
| person.identifier.rid | AHD-2377-2022 |